Compare IRTC & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRTC | ICUI |
|---|---|---|
| Founded | 2006 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 3.9B |
| IPO Year | 2016 | 1995 |
| Metric | IRTC | ICUI |
|---|---|---|
| Price | $114.02 | $125.37 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 5 |
| Target Price | ★ $207.54 | $182.25 |
| AVG Volume (30 Days) | ★ 569.7K | 238.1K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 61.71 | ★ 100.62 |
| EPS | N/A | ★ 0.03 |
| Revenue | $747,138,000.00 | ★ $2,231,262,000.00 |
| Revenue This Year | $19.58 | N/A |
| Revenue Next Year | $15.95 | $4.46 |
| P/E Ratio | ★ N/A | $4,135.83 |
| Revenue Growth | ★ 26.24 | N/A |
| 52 Week Low | $92.52 | $107.02 |
| 52 Week High | $210.01 | $160.29 |
| Indicator | IRTC | ICUI |
|---|---|---|
| Relative Strength Index (RSI) | 35.31 | 37.07 |
| Support Level | $112.31 | $122.17 |
| Resistance Level | $184.04 | $125.00 |
| Average True Range (ATR) | 4.33 | 4.84 |
| MACD | 1.37 | 0.15 |
| Stochastic Oscillator | 27.13 | 15.61 |
iRhythm Holdings Inc formerly, iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.